Skip to main content
. 2016 Dec 10;8(1):1714–1724. doi: 10.18632/oncotarget.13852

Figure 4. NEDD9 regulated cancer stem cell phenotype in hepatocellular carcinoma cells.

Figure 4

A. Sphere formation assays were used to test sphere-forming abilities of MHCC97H cells. Scale bar, 100 μm. B and C. Fluorescence-activated cell sorting analysis showed increased cancer stem cell (CSC) markers ALDH, and CD133 in NEDD9-overexpressing MHCC97H cells. D. Western blots were used to test indicated CSC markers Oct-2, Nanog and Sox2 in hepatocellular carcinoma cells. * p <0.01 compared to control cells.